Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
K-W JoT S Shim

Abstract

A tertiary referral centre in Seoul, South Korea. To investigate the effect of moxifloxacin (MFX) susceptibility and later-generation fluoroquinolone (FQ) use on the treatment outcomes of ofloxacin (OFX) resistant multidrug-resistant tuberculosis (MDR-TB). Of 223 patients diagnosed with MDR-TB between January 2006 and December 2012, 70 (31.4%) patients with OFX-resistant MDR-TB were enrolled in this retrospective cohort study. Their treatment outcomes were analysed. The mean age (standard deviation) of the 70 patients was 40.6 (12.9) years; 43 (61.4%) were male and 26 (37.1%) had extensively drug-resistant TB. Of the 70 patients, 22 (31.4%) had MFX-susceptible TB, while the remaining 48 (68.6%) were MFX-resistant. The MFX-susceptible and -resistant groups were comparable in terms of baseline characteristics (including age, sex and radiological severity), and respectively 90.9% (20/22) and 70.8% (34/48) were treated with later-generation FQ-containing regimens (P = 0.074; mainly MFX [40/54, 74.1%]). Treatment success was achieved in 72.7% (16/22) of the MFX-susceptible patients and in 41.7% (20/48) of the MFX-resistant patients (P = 0.021). Treatment failure was significantly higher in the MFX-resistant group (41.7% [20/48] vs. ...Continue Reading

Citations

Mar 27, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kauser JabeenRumina Hasan
Jul 5, 2016·Expert Review of Clinical Pharmacology·Arnold MafukidzeJennifer Furin
May 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marva SeifertTimothy C Rodwell
May 25, 2016·Antimicrobial Agents and Chemotherapy·Jung-Yien ChienPo-Ren Hsueh
Jun 15, 2016·Antimicrobial Agents and Chemotherapy·Areeya DisratthakitAngkana Chaiprasert
Jul 7, 2017·The European Respiratory Journal·Jose A CamineroGiovanni Battista Migliori
Mar 24, 2017·The European Respiratory Journal·Mayara Lisboa BastosDick Menzies
Mar 21, 2019·The Cochrane Database of Systematic Reviews·Bhagteshwar SinghDerek J Sloan
Mar 7, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marian LovedayJames A Seddon
Mar 12, 2016·International Journal of Mycobacteriology·Dmytro O ButovTatyana S Butova
Mar 24, 2017·The International Journal of Psycho-analysis·Sebastian Leikert
Jan 21, 2021·PLoS Neglected Tropical Diseases·Qiao LiuJianming Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
H-J KimJ H Lee
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
H-J KimD K Kim
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
S-W UmD K Kim
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
S RyuS Kang
© 2021 Meta ULC. All rights reserved